That's essential, since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (first lady). And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a development practically no one noticed. However it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (melania trump). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe significantly before going higher - jeff brown stock market prediction. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. But that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. korean actress. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many excellent personal business on the edge of striking the public markets And I've been dealing with a new method for you to invest even before these companies go public.
This chance has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your area for complimentary.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (first lady). And when it comes to tech investing, we leave it to the experts. Thankfully, we have a number of such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (bleeding edge). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and predict what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid development and creating incredible chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. self-driving cars. But in spite of what many readers may believe, this is a trend that's just getting begun. Even though the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (melania trump). Losing 2 months of manufacturing and sales truly impacts the number of 5G gadgets are sold in the calendar year. When you think about all of that, offering 250 million systems is impressive. More notably, the delays brought on by the pandemic produced a lots of bottled-up need. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G gadgets will be delivered in 2021 - biotech stocks. Which's not my only 5G prediction When I've discussed 5G in the past, I have actually explained its 3 various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services start to be provided (biotech stock). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage 3 by this summertime. This begins something of a virtuous cycle: The majority of people don't actually care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open a suite of incredible applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable concept but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can fix these "typos." For many years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were really only 3 business running in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire industry is successfully a greenfield opportunity.
There's space for many companies to exist in this space. jeff brown biotech genome sequencing. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is very important because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been a trial-and-error process. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however several drug treatments produced using this technology. This was among those advancements that practically no one saw. However it's going to have profound ramifications for treating illness. And, obviously, there will be lots of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back perhaps considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown 1 biotech. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. social media. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date since February 2021, however we might not individually verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to pick winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent point of view on the market. He's always on the hunt for new chances, and he shares much of his finest picks in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he successfully predicted some of the greatest economic events of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right every time, but Jeff Brown's accurate forecasts have actually made him legions of devoted fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research study provides several research study services with a wide array of expertises - the legacy report predictions.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - diplomatic relations. On its website, Brownstone says its objective is to offer retail financiers with professional-grade research: "For too long, the best financial investment research has actually not been readily available to private investors. It has been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. tech predictions. The objective of Brownstone Research is to make that sort of proprietary research study offered to any investors seeking to get an edge in the marketplaces. The goal is basic to provide unique and rewarding financial investment research found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. jeff brown latest prediction. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. tech stock. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced innovations: artificial intelligence and electrical cars and trucks. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you understand, electric vehicles and self-driving car stocks have been big this year, however the Wall Street machine has actually been huge on buzz without much concrete result. Despite a drastic boost in competition over the previous few years, Brown still believes Musk has the best opportunity of putting it all together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transportation. Essentially, this technology would permit you to rent your cars and truck as a self-governing, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the revenues. It sounds crazy, however it might be closed than you think.